3D BIO-TISSUES LIMITED

11666403
Active Newcastle Upon Tyne
12 employees website.com
Life sciences and medical technology
3

3D BIO-TISSUES LIMITED

11666403
Founded 8 Nov 2018 Active Newcastle Upon Tyne, England 12 employees website.com
Life sciences and medical technology
Accounts Submitted 27 Jun 2025 Next due 30 Jun 2026 11 days remaining
Confirmation Submitted 28 Jul 2025 Next due 11 Aug 2026 1 month remaining
Net assets £-2M £996K 2024 year on year
Total assets £404K £28K 2024 year on year
Total Liabilities £3M £968K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Biosphere Draymans Way Newcastle Helix Newcastle Upon Tyne NE4 5BX England

Email

info@example.com

Website

www.example.com

Full company profile for 3D BIO-TISSUES LIMITED (11666403), an active life sciences and medical technology company based in Newcastle Upon Tyne, England. Incorporated 8 Nov 2018. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2024
Type total-exemption-full
Next accounts 30 Sept 2025
Due by 30 Jun 2026 11 days remaining

Balance Sheet & P&L (2019–2024)

Cash in Bank

£179.68k

Decreased by £17.45k (-9%)

Net Assets

-£2.10M

Decreased by £995.62k (-90%)

Total Liabilities

£2.51M

Increased by £967.65k (+63%)

Turnover

N/A

Employees

12

Increased by 3 (+33%)

Debt Ratio

621%

Increased by 264 (+74%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Sept Year End
2023
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 3Nov 2021Seed

Officers

Officers

3 active
Status
Che John ConnonDirectorBritishUnited Kingdom548 Nov 2018Active
Geoffrey Robert BakerDirectorAustralianEngland699 Aug 2019Active
Min YangDirectorAustralianHong Kong599 Aug 2019Active

Shareholders

Shareholders (1)

Bsf Enterprise Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased
Active
Notified 17 May 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Professor Che John Connon

Ceased 17 May 2022

Ceased

Bsf Angel Funding Limited

Ceased 17 May 2022

Ceased
Ceased

Group Structure

Group Structure

BSF ENTERPRISE PLC united kingdom
3D BIO-TISSUES LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Sept 2025OfficersTermination of Min Yang as director on 3 Sept 2025
28 Jul 2025Confirmation StatementConfirmation statement made on 28 Jul 2025 with no updates
17 Jul 2025OtherAudit exemption statement of guarantee by parent company for period ending 30/09/24
27 Jun 2025AccountsAnnual accounts made up to 30 Sept 2024
11 Jun 2025OtherNotice of agreement to exemption from audit of accounts for period ending 30/09/24
3 Sept 2025 Officers

Termination of Min Yang as director on 3 Sept 2025

28 Jul 2025 Confirmation Statement

Confirmation statement made on 28 Jul 2025 with no updates

17 Jul 2025 Other

Audit exemption statement of guarantee by parent company for period ending 30/09/24

27 Jun 2025 Accounts

Annual accounts made up to 30 Sept 2024

11 Jun 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 30/09/24

Recent Activity

Latest Activity

Termination of Min Yang as director on 3 Sept 2025

9 months ago on 3 Sept 2025

Confirmation statement made on 28 Jul 2025 with no updates

10 months ago on 28 Jul 2025

Audit exemption statement of guarantee by parent company for period ending 30/09/24

11 months ago on 17 Jul 2025

Annual accounts made up to 30 Sept 2024

11 months ago on 27 Jun 2025

Notice of agreement to exemption from audit of accounts for period ending 30/09/24

1 years ago on 11 Jun 2025